C. Hariton

622 total citations
24 papers, 516 citations indexed

About

C. Hariton is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Hariton has authored 24 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Hariton's work include Neuroscience and Neuropharmacology Research (7 papers), Renal cell carcinoma treatment (3 papers) and Cancer, Lipids, and Metabolism (3 papers). C. Hariton is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Renal cell carcinoma treatment (3 papers) and Cancer, Lipids, and Metabolism (3 papers). C. Hariton collaborates with scholars based in France, Canada and Switzerland. C. Hariton's co-authors include Robert Salvayre, Christian Schnell, Gerald Batist, Bernard Escudier, Carey Levinton, J.L. Bellot, É. Dupont, David Croteau, François Patenaude and Éric Dupont and has published in prestigious journals such as The Journal of Urology, Annals of Oncology and Biochemical Pharmacology.

In The Last Decade

C. Hariton

24 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Hariton France 12 191 104 91 90 76 24 516
Hongxi Wu China 13 291 1.5× 98 0.9× 93 1.0× 92 1.0× 132 1.7× 25 747
Guifang Jin China 15 363 1.9× 126 1.2× 96 1.1× 30 0.3× 59 0.8× 24 743
Marie‐Claude Carrière Canada 13 275 1.4× 47 0.5× 30 0.3× 97 1.1× 77 1.0× 14 927
Lokman Ayaz Türkiye 17 392 2.1× 293 2.8× 90 1.0× 53 0.6× 50 0.7× 48 795
June O’Neil United States 17 380 2.0× 43 0.4× 60 0.7× 16 0.2× 46 0.6× 23 768
Kenji Katsuno Japan 12 372 1.9× 27 0.3× 84 0.9× 33 0.4× 95 1.3× 15 1.0k
Junfei Gu China 19 552 2.9× 205 2.0× 25 0.3× 103 1.1× 86 1.1× 42 879
Mee Young Choi South Korea 12 238 1.2× 42 0.4× 49 0.5× 23 0.3× 37 0.5× 16 372
Guy Miller United States 12 620 3.2× 87 0.8× 18 0.2× 116 1.3× 34 0.4× 27 945
Stéphanie Lemaire‐Ewing France 18 674 3.5× 100 1.0× 21 0.2× 37 0.4× 100 1.3× 25 1.2k

Countries citing papers authored by C. Hariton

Since Specialization
Citations

This map shows the geographic impact of C. Hariton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Hariton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Hariton more than expected).

Fields of papers citing papers by C. Hariton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Hariton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Hariton. The network helps show where C. Hariton may publish in the future.

Co-authorship network of co-authors of C. Hariton

This figure shows the co-authorship network connecting the top 25 collaborators of C. Hariton. A scholar is included among the top collaborators of C. Hariton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Hariton. C. Hariton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Latreille, Jean, Gerald Batist, Francis Laberge, et al.. (2003). Phase I/II Trial of the Safety and Efficacy of AE-941 (Neovastat®) in the Treatment of Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 4(4). 231–236. 40 indexed citations
2.
Jagannath, Sundar, et al.. (2003). Neovastat in multiple myeloma. European Journal Of Haematology. 70(4). 267–268. 1 indexed citations
3.
Batist, Gerald, François Patenaude, David Croteau, et al.. (2002). Neovastat (Æ-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels. Annals of Oncology. 13(8). 1259–1263. 72 indexed citations
4.
5.
Schnell, Christian, et al.. (1996). Continuous intraocular pressure measurement by telemetry in alpha-chymotrypsin-induced glaucoma model in the rabbit: Effects of timolol, dorzolamide, and epinephrine. Journal of Pharmacological and Toxicological Methods. 36(4). 223–228. 56 indexed citations
6.
Bellot, J.L., et al.. (1996). Additive effect of nitric oxide and prostaglandin-E2 synthesis inhibitors in endotoxin-induced uveitis in the rabbit. Inflammation Research. 45(4). 203–208. 66 indexed citations
7.
Hariton, C., et al.. (1995). Allergic conjunctivitis and uveitis models: Reappraisal with some marketed drugs. Inflammation Research. 44(1). 47–54. 15 indexed citations
8.
Hariton, C.. (1994). Ocular hypotension induced by topical dopaminergic drugs and phosphodiesterase inhibitors. European Journal of Pharmacology. 258(1-2). 85–94. 12 indexed citations
9.
Hariton, C.. (1992). Biphasic dose‐dependent effects of dopamine and involvement of dopamine autoreceptors on intra‐ocular pressure in the rabbit. Journal of Autonomic Pharmacology. 12(5). 335–347. 9 indexed citations
10.
11.
Hariton, C., et al.. (1991). Ocular pharmacokinetics of calcium, chloride and sulphate ions after instillation in the rabbit. Biopharmaceutics & Drug Disposition. 12(6). 403–410. 2 indexed citations
12.
Nègre‐Salvayre, Anne, et al.. (1991). Protective effect of α-tocopherol, ascorbic acid and rutin against peroxidative stress induced by oxidized lipoproteins on lymphoid cell lines. Biochemical Pharmacology. 42(2). 450–453. 23 indexed citations
13.
Hariton, C., et al.. (1990). Transitory models of experimentally induced intraocular pressure changes in the rabbit. Journal of Pharmacological Methods. 24(2). 79–88. 5 indexed citations
14.
Hariton, C., G Jadot, A.M. Michelson, & P. Mandel. (1989). Superoxide dismutase treatment reduces [3H]flunitrazepam affinity in cortex and hippocampus of the rat. Neuroscience Letters. 102(2-3). 313–318. 4 indexed citations
15.
Deby, C., et al.. (1989). Decreased Tocopherol Concentration of Varicose Veins is Associated with a Decrease in Antilipoperoxidant Activity without Similar Changes in Plasma. Phlebology The Journal of Venous Disease. 4(2). 113–121. 7 indexed citations
16.
Hariton, C., L Ciesielski, Jean Paul Cano, & P. Mandel. (1988). Studies on benzodiazepine receptor subtypes in a model of chronic spontaneous petit mal-like seizures. Neuroscience Letters. 84(1). 97–102. 11 indexed citations
17.
Hariton, C., et al.. (1986). Fundamental aspects of radioreceptor assays. Journal of Pharmaceutical and Biomedical Analysis. 4(6). 697–716. 17 indexed citations
18.
Hariton, C., et al.. (1985). Valproate increases diazepam impregnation selectively in CNS of the rat after subchronic administration. Life Sciences. 37(14). 1343–1349. 2 indexed citations
19.
Hariton, C., G Jadot, M Valli, E Mesdjian, & P. Mandel. (1985). Effects of Sodium Valproate on Diazepam: Kinetic Profiles in Plasma, Erythrocytes, and Different Brain Areas in the Rat. Epilepsia. 26(1). 74–80. 3 indexed citations
20.
Hariton, C., L Ciesielski, S Simler, et al.. (1984). Distribution of sodium valproate and gaba metabolism in cns of the rat. Biopharmaceutics & Drug Disposition. 5(4). 409–414. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongxi Wu Breakdown of academic impact, for papers by Guifang Jin Breakdown of academic impact, for papers by Marie‐Claude Carrière Breakdown of academic impact, for papers by Lokman Ayaz Breakdown of academic impact, for papers by June O’Neil Breakdown of academic impact, for papers by Kenji Katsuno Breakdown of academic impact, for papers by Junfei Gu Breakdown of academic impact, for papers by Mee Young Choi Breakdown of academic impact, for papers by Guy Miller Breakdown of academic impact, for papers by Stéphanie Lemaire‐Ewing
Rankless by CCL
2026